(S (NP (NP (JJ Quantitative) (NN extraction)) (PP (IN of) (NP (JJ high-dimensional) (JJ mineable) (NNS data))) (PP (IN from) (NP (JJ medical) (NNS images)))) (VP (VBZ is) (NP (NP (DT a) (NN process)) (VP (VBN known) (PP (IN as) (NP (NNS radiomics)))))) (. .))
(S (NP (NNS Radiomics)) (VP (VBZ is) (VP (JJ foreseen) (PP (IN as) (NP (NP (DT an) (JJ essential) (JJ prognostic) (NN tool)) (PP (IN for) (NP (NP (NN cancer) (NN risk) (NN assessment)) (CC and) (NP (NP (DT the) (NN quantification)) (PP (IN of) (NP (JJ intratumoural) (NN heterogeneity)))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN work))) (, ,) (NP (NP (CD 1615) (JJ radiomic) (NNS features)) (PRN (-LRB- -LRB-) (VP (VBG quantifying) (NP (NN tumour) (NN image) (NN intensity) (, ,) (NN shape) (, ,) (NN texture))) (-RRB- -RRB-)) (VP (VBD extracted) (PP (IN from) (NP (NP (JJ pre-treatment) (NNP FDG-PET) (CC and) (NNP CT) (NNS images)) (PP (IN of) (NP (NP (CD 300) (NNS patients)) (PP (IN from) (NP (CD four) (JJ different) (NNS cohorts))))))))) (VP (VBD were) (VP (VBN analyzed) (PP (IN for) (NP (NP (DT the) (NN risk) (NN assessment)) (PP (IN of) (NP (NP (NP (NP (JJ locoregional) (NNS recurrences)) (PRN (-LRB- -LRB-) (NP (NNP LR)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ distant) (NNS metastases)) (PRN (-LRB- -LRB-) (NP (NNP DM)) (-RRB- -RRB-)))) (PP (IN in) (NP (NN head-and-neck) (NN cancer))))))))) (. .))
(S (NP (NP (NN Prediction) (NNS models)) (VP (VBG combining) (NP (UCP (JJ radiomic) (CC and) (JJ clinical)) (NNS variables)))) (VP (VBD were) (VP (VBN constructed) (PP (IN via) (NP (NP (NN random) (NNS forests)) (CC and) (NP (JJ imbalance-adjustment) (NNS strategies)))) (S (VP (VBG using) (NP (NP (CD two)) (PP (IN of) (NP (DT the) (CD four) (NNS cohorts)))))))) (. .))
(S (NP (NP (JJ Independent) (NN validation)) (PP (IN of) (NP (NP (DT the) (NN prediction) (CC and) (JJ prognostic) (NN performance)) (PP (IN of) (NP (DT the) (NNS models)))))) (VP (VBD was) (VP (VBN carried) (PRT (RP out)) (PP (IN on) (NP (NP (DT the) (JJ other) (CD two) (NNS cohorts)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP LR)) (: :) (S (S (NP (NNP AUC)) (VP (VBZ =) (NP (CD 0.69)))) (CC and) (S (NP (NNP CI)) (VP (NNP =) (NP (CD 0.67)))))) (: ;) (NP (NP (NNP DM)) (: :) (S (S (NP (NNP AUC)) (VP (VBZ =) (NP (CD 0.86)))) (CC and) (S (NP (NNP CI)) (VP (NNP =) (NP (CD 0.88))))))) (-RRB- -RRB-)))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP (NP (DT the) (NNS results)) (VP (VBD obtained) (PP (IN via) (NP (NNP Kaplan-Meier) (NN analysis))))) (VP (VBD demonstrated) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (NNS radiomics))) (PP (IN for) (S (VP (VBG assessing) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ specific) (NN tumour) (NNS outcomes)))) (S (VP (VBG using) (NP (JJ multiple) (NN stratification) (NNS groups))))))))) (. .))
(S (NP (DT This)) (VP (MD could) (VP (VB have) (NP (JJ important) (JJ clinical) (NN impact)) (, ,) (PP (ADVP (RB notably)) (IN by) (S (VP (VBG allowing) (PP (IN for) (NP (NP (DT a) (JJR better) (NN personalization)) (PP (IN of) (NP (NP (NN chemo-radiation) (NNS treatments)) (PP (IN for) (NP (NP (JJ head-and-neck) (NN cancer) (NNS patients)) (PP (IN from) (NP (JJ different) (NN risk) (NNS groups)))))))))))))) (. .))
